Comparison of technetium 99m polyclonal human immunoglobulin and technetium 99m monoclonal antibodies for imaging chronic osteomyelitis. First clinical results. 1991

J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
Klinik und Poliklinik für Nuklearmedizin, Westfälische Wilhelms-Universität Münster, Federal Republic of Germany.

The accuracy of technetium-99m human immunoglobulin (HIG) for the detection of chronic osteomyelitis (OM) was compared with white blood cell scintigraphy using 99mTc-labelled monoclonal mouse antibodies (MAB). Seventeen patients suspected of having OM in 20 lesions went through three-phase skeletal scintigraphy, HIG scintigraphy and MAB scintigraphy. The final diagnosis was established by open surgery, histology and bacteriology. Chronic OM was proved in 14/20 lesions. Six of these 14 infections were located in peripheral areas without active bone marrow and 8/14 in central areas with active bone marrow. In peripheral OM, 5/6 with HIG and 6/6 with MAB were true positives. In the central skeleton all 8/8 infections appeared as cold lesions in the MAB study, which were defined as being false negative due to their non-specificity. Using HIG, 5/8 central infections were determined to be truly positive by showing photon-rich lesions. These 5 lesions were located in the hip region and in the pelvis, whereas 3 lesions of the spine were missed. There were no false-positive results in either studies. In conclusion, MAB was superior to HIG in peripheral OM concerning sensitivity, anatomical landmarks and differentiation of soft tissue versus bone infection. In central OM MAB detected all lesions accurately, but no differential diagnosis was possible due to the non-specificity of photon-low areas. In this respect HIG seems to be more specific due to the increased accumulation even in central infection sites.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
April 1994, European journal of nuclear medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
September 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
October 1996, European journal of nuclear medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
May 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
April 1996, European journal of nuclear medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
November 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
May 1999, European journal of nuclear medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
January 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
September 2000, Clinical nuclear medicine,
J Sciuk, and W Brandau, and B Vollet, and R Stücker, and R Erlemann, and P Bartenstein, and P E Peters, and O Schober
May 2002, Nuclear medicine and biology,
Copied contents to your clipboard!